Nanjing Bioheng Biotech Co., Ltd.
Clinical trials sponsored by Nanjing Bioheng Biotech Co., Ltd., explained in plain language.
-
Engineered immune cells take on lupus and other autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-T) to target and calm overactive immune cells in people with autoimmune diseases like lupus, scleroderma, and Sjogren's syndrome. About 20 adults aged 18 to 70 with active disease will receive either CD…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 04:08 UTC
-
Engineered immune cells take aim at lupus and MS
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, which uses a patient's own immune cells modified to target and calm overactive immune cells in autoimmune diseases. The trial includes 18 adults with conditions like lupus, systemic sclerosis, multiple sclerosis, and ot…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC